XW
Xiancheng Wu
Credentials:
History
- 2021–2024
Residency
- 2017–2021
Medical School
Research
CD24 Expression and differential resistance to chemotherapy in triple-negative breast cancer
Oncotarget · 2017 · 48 citations
Belzutifan for the treatment of renal cell carcinoma
Review · Therapeutic Advances in Medical Oncology · 2025 · First of 4 authors · Corresponding · 27 citations
Journal of Nuclear Medicine · 2022 · 10 citations
- JH
3 papers · 3 as a fellow
3 papers
2 papers
2 papers
2 papers · 2 as a fellow
2 papers
2 papers
2 papers
